Pharmaceuticals
EPO decision clears way for Sanofi blockbuster drug Praluent
The Higher Regional Court Düsseldorf is allowing Sanofi to sell its competing cholesterol-lowering drug Praluent in Germany again, following yesterday
...
6 November 2020 by Mathieu Klos